Cite
Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
MLA
Qiang Chen, et al. “Corrigendum: Case Report: Deterioration of Infantile Hemangioma Related to Oral or Nebulized Administration of Β2-AR Agonist: Three Cases Reports.” Frontiers in Oncology, vol. 13, Sept. 2023. EBSCOhost, https://doi.org/10.3389/fonc.2023.1282607.
APA
Qiang Chen, Yunxuan Zhang, Chenyu Sun, Li Liu, Xiaoyan Luo, Hua Wang, & Sili Ni. (2023). Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1282607
Chicago
Qiang Chen, Yunxuan Zhang, Chenyu Sun, Li Liu, Xiaoyan Luo, Hua Wang, and Sili Ni. 2023. “Corrigendum: Case Report: Deterioration of Infantile Hemangioma Related to Oral or Nebulized Administration of Β2-AR Agonist: Three Cases Reports.” Frontiers in Oncology 13 (September). doi:10.3389/fonc.2023.1282607.